An Open-label Trial of Risperidone Long-acting Injectable in the Treatment of Subjects With Recent Onset Psychosis.
Phase of Trial: Phase III
Latest Information Update: 22 Mar 2013
At a glance
- Drugs Risperidone (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 19 Oct 2007 Status changed from in progress to completed.
- 13 Nov 2005 New trial record.